Efficacy and safety of bronchial arterial chemoembolization (BACE) in combination with tislelizumab for non-small cell lung cancer (NSCLC): A phase II study.
Genomic landscape of MTAP deletions and association with EGFR alterations in NSCLC. A phase 2, multicenter, open-label, dose-optimization study evaluating telomere-targeting agent THIO sequenced with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results